TIME

TIME

TIME is a worldwide media brand that has established itself over a century of trust and credibility. It reaches an audience of over 100 million across various platforms. Our team works closely together, using creativity and dedication to fulfill TIME’s mission of providing insightful information, engaging stories, and interactive experiences through exceptional journalism and live events.

International
English
Magazine

Outlet metrics

Domain Authority
94
Ranking

Global

#5215

United States

#1443

News and Media

#98

Traffic sources
Monthly visitors

Articles

  • 1 day ago | time.com | Andrew Chow

    AI models could help fight disease—but they also pose a deadly risk if weaponized by non-experts.

  • 3 days ago | time.com | Justin Worland

    Jorge Mario Bergoglio’s first big environmental move after being elected leader of the world’s more than 1.2 billion Catholics came quickly: choosing the papal name Francis after Saint Francis of Assi, known among other things for his appreciation of the natural world which he called a “mirror of God.” That was 2013. In his 12 year papacy, Pope Francis would go on to become a key figure in the global climate movement.

  • 3 days ago | time.com | Eliana Dockterman

    Warning: This post contains spoilers for The Last of Us Season 2, Episode 2. Let’s get right to it: In the second episode of Season 2 of The Last of Us, a woman named Abby (Kaitlyn Dever) brutally murders Joel (Pedro Pascal) in front of Ellie (Bella Ramsey). This may have come as a shock to those unfamiliar with the game, but not to those who played as both Ellie and Abby in The Last of Us Part II.

  • 5 days ago | time.com | Chantelle Lee

    Amid the measles outbreak that started in Texas and is now believed to have spread to four other states, many people might be wondering: do I need to get a measles vaccine booster? Measles is a highly contagious airborne disease that can lead to severe complications, including death. It’s also vaccine preventable through the measles, mumps, and rubella (MMR) vaccine, which is typically administered in childhood in two doses.

  • 5 days ago | time.com | Justin Worland

    Votes to elect board members of major corporations are typically pro forma affairs. Companies make their recommendations, and shareholders certify it, usually with near unanimity. That wasn’t the case this week at BP’s closely watched annual meeting. On Thursday, nearly a quarter of BP’s shareholders voted against the oil and gas major’s current chairman. It was a stunning rebuke of the company’s management. The dissatisfaction with BP’s direction is driven by a constellation of factors.